2-fluoro-N-(4-hydroxy-10-aza-tricyclo[6.3.1.02,7]-dodeca-2(7),3,5-trien-5-yl)-benzamide | 357425-27-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯氮卓类
• 英文名称: 2-fluoro-N-(4-hydroxy-10-aza-tricyclo[6.3.1.02,7]-dodeca-2(7),3,5-trien-5-yl)-benzamide
• 英文别名: 2-fluoro-N-(5-hydroxy-10-azatricyclo[6.3.1.02,7]dodeca-2,4,6-trien-4-yl)benzamide
• CAS: 357425-27-5
• 化学式: C₁₈H₁₇FN₂O₂
• 分子量: 312.344
• InChiKey: DZISRADTOTWBQZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  23
• 可旋转键数：
  2
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  61.4
• 氢给体数：
  3
• 氢受体数：
  4

文献信息

• Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic componunds
  申请人：——

  公开号：US20030060624A1

  公开（公告）日：2003-03-27

  The present invention relates to processes for the preparation of any of the intermediate 1,3-substituted indenes of the formulae (Ia), (Ib) and (Ic) or a mixture thereof: 1 wherein R 1 , R 2 , R 3 , R 4 , and R 5 are defined herein. Compounds of formulae (Ia), (Ib) and (IC) or mixtures thereof are useful in the preparation of compounds of formula (II): 2 wherein R 2 , R 3 and R 6 are also defined herein.

  本发明涉及制备公式(Ia)、(Ib)和(Ic)中任一中间体1,3-取代吲哚的过程，或其混合物： 其中R1、R2、R3、R4和R5在此处定义。公式(Ia)、(Ib)和(Ic)或其混合物的化合物在制备公式(II)的化合物中有用： 其中R2、R3和R6也在此处定义。
• Nicontinic acetylcholine receptor antagonists in the treatment of restless legs syndrome
  申请人：Pfizer Inc.

  公开号：US20030134844A1

  公开（公告）日：2003-07-17

  This invention relates to the use of nicotinic acetylcholine receptor agonists for the treatment of restless legs syndrome (RLS). The invention further relates to the use of a nicotinic acetylcholine receptor agonist in the manufacture of a medicament for the treatment of RLS. The present invention also relates to a pharmaceutical composition for the treatment of RLS containing a nicotinic acetylcholine receptor agonist.

  这项发明涉及尼古丁型乙酰胆碱受体激动剂用于治疗不安腿综合征（RLS）。该发明还涉及尼古丁型乙酰胆碱受体激动剂在制造治疗RLS药物中的应用。本发明还涉及一种含有尼古丁型乙酰胆碱受体激动剂的治疗RLS的药物组合物。
• [EN] PROCESS FOR THE PREPARATION OF 1,3-SUBSTITUTED INDENES AND ARYL-FUSED AZAPOLYCYCLIC COMPOUNDS<br/>[FR] PROCEDE DE PREPARATION D'INDENES 1,3-SUBSTITUES ET COMPOSES AZAPOLYCYCLIQUES D'ARYLE FONDUS
  申请人：PFIZER PROD INC

  公开号：WO2002085843A2

  公开（公告）日：2002-10-31

  The present invention relates to processes for the preparation of any of the intermediate 1,3-substituted indenes of formulae (Ia, Ib and Ic) or a mixture thereof, wherein R?1, R2, R3, R4, and R5¿ are defined herein. Compounds of formulae (Ia, Ib and Ic) or mixtures thereof are useful in the preparation of compounds of formula (II), wherein R?2, R3 and R6¿ are also defined herein.

  本发明涉及制备公式(Ia、Ib和Ic)中的任何1,3-取代茚芝中间体或其混合物的过程，其中R1、R2、R3、R4和R5在此定义。公式(Ia、Ib和Ic)化合物或其混合物在制备公式(II)中的化合物中有用，其中R2、R3和R6在此也被定义。
• Aryl fused azapolycyclic compounds
  申请人：——

  公开号：US20020111350A1

  公开（公告）日：2002-08-15

  Compounds of the formula 1 and their pharmaceutically acceptable salts, wherein R 1 , R 2 , R 3 and n are defined as in the specification, intermediates in the synthesis of such compounds, pharmaceutical compositions containing such compounds and methods of using such compounds in the treatment of neurological and psychological disorders are claimed.

  本发明涉及化合物1及其药用可接受的盐，其中R1、R2、R3和n如规范中所定义，以及合成此类化合物的中间体，含有此类化合物的制药组合物以及使用此类化合物治疗神经和心理障碍的方法。
• Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
  申请人：Singer A. Robert

  公开号：US20060079707A1

  公开（公告）日：2006-04-13

  The present invention relates to processes for the preparation of any of the intermediate 1,3-substituted indenes of the formulae (Ia), (Ib) and (Ic) or a mixture thereof: wherein R 1 , R 2 , R 3 , R 4 , and R 5 are defined herein. Compounds of formulae (Ia), (Ib) and (Ic) or mixtures thereof are useful in the preparation of compounds of formula (II): wherein R 2 , R 3 and R 6 are also defined herein.

  本发明涉及制备公式(Ia)、(Ib)和(Ic)中任何一种或其混合物的中间体1,3-取代茚的过程：其中R1、R2、R3、R4和R5的定义如本文所述。 公式(Ia)、(Ib)和(Ic)或其混合物的化合物在制备公式(II)的化合物中有用：其中R2、R3和R6的定义也如本文所述。